Tenax Therapeutics Inc.

NASDAQ: TENX
Share price (12/20/24): $5.61
Market cap (12/20/24): $19.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from SCHEDULE 13G Underwriting agreement

from S-1/A 16 pages Placement Agency Agreement [•], 2023

from SC 13G 1 page Joint Filing Agreement Pursuant to Rule 13d-1

from 8-K 29 pages 5,181,346 Shares of Series a Convertible Preferred Stock (Convertible Into 5,181,346 Shares of Common Stock), and 10,362,692 Warrants (Exercisable for 10,362,692 Shares of Common Stock) of Tenax Therapeutics, Inc. Underwriting Agreement

from S-1/A 29 pages Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), and Warrants (Exercisable for Shares of Common Stock) of Tenax Therapeutics, Inc. Underwriting Agreement

from S-3 20 pages Tenax Therapeutics, Inc. $40,000,000 Sales Agreement

from 424B3 20 pages 9,285,714 Shares of Common Stock of Oxygen Biotherapeutics, Inc. Underwriting Agreement

from 8-K 20 pages 9,285,714 Shares of Common Stock of Oxygen Biotherapeutics, Inc. Underwriting Agreement

from 8-K 26 pages Placement Agency Agreement December 8, 2011

from 8-K 37 pages Placement Agency Agreement May 4, 2010

from 10-Q ~10 pages Agreement Dated 9/17